Anthropic has introduced Claude Design, a cutting-edge AI tool from its Anthropic Labs division, enabling users to create polished visual content, including designs, interactive prototypes, presentations, and marketing materials through conversational prompts and precise editing controls. This product, now available to all paid Claude subscribers in research preview, marks Anthropic's bold foray from language models into design applications traditionally dominated by Figma, Adobe, and Canva. Powered by the robust Claude Opus 4.7 vision model, Claude Design streamlines a collaborative creative workflow where users can generate initial designs from text prompts and refine through chat, inline editing, and customizable sliders. Teams can import and manage design systems drawn from their codebases, images, or live websites, producing prototypes that closely resemble real products. Notably, Claude Design offers seamless handoff to Claude Code for full production-ready builds and supports exports to common formats and platforms like Canva and PPTX. Early users have lauded its efficiency, with complex design tasks requiring significantly fewer prompts than competitors. This launch occurs alongside Mike Krieger’s resignation from Figma’s board, signaling shifting dynamics in design tool ecosystems. Despite positioning itself as complementary to existing tools, Claude Design’s accessibility to non-designers and end-to-end capabilities pose a potential challenge to established players. The underlying Claude Opus 4.7 model emphasizes safety and strong vision processing but intentionally limits cybersecurity risks, differentiating it from Anthropic’s more powerful but restricted Mythos model. Enterprise users benefit from robust data privacy measures and flexible pricing integrated into existing subscription plans. As Anthropic continues to expand its product suite—encompassing coding, knowledge work, and office integrations—it aims to create a unified AI-driven creative stack, radically transforming how products move from concept to launch. This move comes amid strong financial backing, an approaching IPO, and the complex implications of competing with key industry partners.
According to LUMA Partners' Q1 report, macroeconomic challenges have slowed dealmaking in the ad tech and martech sectors. Despite this cooling trend, investments in AI continue to attract strong interest as the most sought-after area.
This month, Puma introduced an AI-powered digital concierge named "Dylan" at its Las Vegas flagship store. Despite leveraging advanced technology, Puma remains committed to empowering consumers by giving them control over their shopping experience.
Social media has dramatically accelerated the pace at which beauty trends influence real-world aesthetic treatments, often pushing consumers to make quick and sometimes uninformed decisions. This disconnect arises because aesthetic inspiration is collective and social, but the results are personal and vary greatly based on individual biology. AI is bridging this gap by providing precise, personalized consultations that predict actual outcomes and help patients align expectations with their unique facial characteristics. Technologies like AI Skin Analysis offer dermatologist-validated diagnostics that personalize skin health assessments, transforming patient education from a clinical luxury into a standard practice. AI visualization tools empower patients to see realistic simulations of treatments like Botox and filler, fostering confidence and trust. Practitioners report increased patient satisfaction, repeat visits, and higher spending when integrating these AI tools. Furthermore, democratized access to AI APIs allows brands and clinics of all sizes to provide personalized skin education, enhancing customer engagement and decision-making. This technological shift marks an inflection point where practitioners and brands can build lasting consumer trust through data-driven, personalized care rather than generic social media trends.
AI companies often make bold promises about revolutionizing healthcare, claiming breakthroughs in scientific discovery and medicine development. Yet, the true measure of success is whether these AI technologies have been proven to work in humans, creating life-saving treatments. Unfortunately, most have yet to meet this standard. Real progress in healthcare demands extensive clinical trials, rigorous testing, and years of effort. Leading AI healthcare companies like Insilico Medicine, Recursion, and Owkin are closing the gap by advancing AI-driven discoveries through clinical trials and training AI models on authentic patient data. This approach fosters a continuous improvement cycle where AI performance is refined through real-world feedback, ultimately benefiting patients. While the excitement around AI’s potential is justified, only the AI that withstands the challenges of clinical reality will truly transform medicine.
Dairy Queen is integrating AI-powered chatbots into dozens of drive-thru locations across the US and Canada to speed up service and encourage larger orders. This rollout follows a successful trial last year and involves technology from Presto, an AI firm that supports other fast food chains like Carl's Jr. and Taco John's. However, reports indicate that human agents in places like the Philippines may assist the chatbot system behind the scenes.
Eindhoven-based neurotechnology firm ONWARD Medical has successfully raised €40.6 million to finance its pivotal Empower BP trial, investigating the efficacy of its implantable ARC-IM® system for managing blood pressure instability following spinal cord injury. The funding will also support the broader commercial expansion of its cleared ARC-EX® external therapy system. With this investment, the company's cash runway is expected to extend through Q1 2028.
Allbirds is making a sharp pivot from its sustainable footwear roots to the tech world by rebranding as NewBird AI. After selling its shoe business to American Exchange Group for $39 million, the company is now focusing on offering GPU-as-a-service cloud computing solutions. They have also raised $50 million through convertible financing. Following a remarkable 600% spike in its stock price, which then dropped by around a third, NewBird AI plans to lease GPUs to companies developing AI applications.
Factory, a startup focused on AI-driven coding solutions for businesses, has secured $150 million in funding, led by Khosla Ventures. Founded just three years ago, the company is rapidly scaling its technology to meet enterprise demands.
Sequoia has initiated its first significant fundraise under the guidance of its new co-leaders, Alfred Lin and Pat Grady. The venture capital firm, with a legacy spanning 54 years, has successfully raised $7 billion to expand its commitment to artificial intelligence ventures.
